Skip to content

Celcuity CELC Convertible Preferred Stock Authorized Shares

Convertible Preferred Stock Authorized Shares at other companies

Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
10M
BridgeBio Pharma logo
BridgeBio PharmaBBIO
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
Exelixis logo
ExelixisEXEL
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.4B+1,370%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's convertible preferred stock authorized shares.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's convertible preferred stock authorized shares?
Celcuity (CELC) reported convertible preferred stock authorized shares of 2.5M in Q1 2026.
How has Celcuity's convertible preferred stock authorized shares changed year-over-year?
Celcuity's convertible preferred stock authorized shares decreased by 0.0% year-over-year, from 2.5M to 2.5M.
What is the long-term trend for Celcuity's convertible preferred stock authorized shares?
Over 5 years (2020 to 2025), Celcuity's convertible preferred stock authorized shares has grown at a 0.0% compound annual growth rate (CAGR), from 2.5M to 2.5M.
What does convertible preferred stock authorized shares mean?
Maximum number of convertible preferred shares the company is authorized to issue under its corporate charter.